K. Possinger

5.0k citations
169 papers · 4.0k · 1 hit paper · h-index 33

Impact in

  • Oncology top 1%
    • Cancer Treatment and Pharmacology
    • HER2/EGFR in Cancer Research
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Breast Cancer Treatment Studies

Papers in

    • Cancer Treatment and Pharmacology 44
    • HER2/EGFR in Cancer Research 20
    • Colorectal Cancer Treatments and Studies 12
    • Breast Cancer Treatment Studies 28
    • Cancer Genomics and Diagnostics 8

K. Possinger

153 papers receiving 3.8k citations

K. Possinger's Hit Papers

Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. 1996 · 571 citations
5710+10+20Years since publication100200300400500

Peers

K. Possinger
Comparison fields: 5 of 140
  • Oncology 1.5k
  • Cancer Research 607
  • Biomaterials 429
  • Hematology 257
  • Pulmonary and Respiratory Medicine 543
Replace William P. Petros with:
William P. Petros United States
S.B. Kaye United Kingdom
Stephan Bodis Switzerland
Christian Dittrich Austria
Sewa S. Legha United States
Claire F. Verschraegen United States
Renzo Canetta United States
Agop Y. Bedikian United States
Mathew L. Thakur United States
Guido Bocci Italy
K. Possinger relative to William P. Petros United States William P. Petros's profile →
Citations per field
00.5×1.5×1.9×
William P. Petros · 1×
Citations per year

Countries citing papers authored by K. Possinger

Since Specialization
Citations

This map shows the geographic impact of K. Possinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Possinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Possinger more than expected).

Fields of papers citing papers by K. Possinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Possinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Possinger. The network helps show where K. Possinger may publish in the future.

Co-authors

The 25 scholars most cited alongside K. Possinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K. Possinger Line = papers co-authored together K. Possinger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 169 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.
Hit paper breakdown →
1996571
2 1995311
3 1998188
4 2001151
5 2000150
6 2003145
7 2000120
8 1999113
9 200277
10
Tumor type M2 pyruvate kinase expression in advanced breast cancer.
200175
11 199072
12 200168
13 200366
14 200063
15 200462
16 200458
17 201255
18 200253
19 200052
20 201250

About K. Possinger

K. Possinger is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Genetics, having authored 169 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (44 papers), Breast Cancer Treatment Studies (28 papers), Advanced Breast Cancer Therapies (22 papers), HER2/EGFR in Cancer Research (20 papers), Estrogen and related hormone effects (13 papers), Colorectal Cancer Treatments and Studies (12 papers), Cancer Genomics and Diagnostics (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (607 citations), Biomaterials (429 citations), Hematology (257 citations) and Pulmonary and Respiratory Medicine (543 citations). K. Possinger has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Orhan Sezer, Jan Eucker, Diana Lüftner, Martin Fenner, Peter Schmid, Jackie Walling, J Carmichael, Helen Kerr, Maria K. Beykirch and Adrian L. Harris. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Annals of Hematology and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact